Breast cancer risk may be increased in women who have first-degree relatives with a history of prostate cancer
2015-03-09
(Press-News.org) Having a family history of prostate cancer among first-degree relatives may increase a woman's risk of developing breast cancer. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results indicate that clinicians should take a complete family history of all cancers--even those in family members of the opposite sex--to help assess a patient's risk of developing cancer.
Evidence suggests that the risk of developing breast and prostate cancer is increased among individuals with a family history of the same disease, particularly among first-degree relatives. However, less is known about the relationship between breast and prostate cancer within families.
To investigate, Jennifer L. Beebe-Dimmer, PhD, MPH, of the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine in Detroit, studied 78,171 women who enrolled in the Women's Health Initiative Observational Study between 1993 and 1998 and were free of breast cancer at the start of the study. During follow-up, which ended in 2009, a total of 3506 breast cancer cases were diagnosed. The researchers found that a family history of prostate cancer in first-degree relatives (fathers, brothers, and sons) was linked with a 14 percent increase in breast cancer risk for women, after adjusting for various patient factors. In separate analyses examining the joint impact of both cancers, a family history of both breast and prostate cancer was linked with a 78 percent increase in breast cancer risk. Risks associated with a family history of both breast and prostate cancer were higher among African American women than white women.
"The increase in breast cancer risk associated with having a positive family history of prostate cancer is modest; however, women with a family history of both breast and prostate cancer among first-degree relatives have an almost 2-fold increase in risk of breast cancer," said Dr. Beebe-Dimmer.
Dr. Beebe-Dimmer noted that patients and physicians may not consider certain cancer diagnoses among family members, especially those in members of the opposite sex, in their assessments of cancer risk. "These findings are important in that they can be used to support an approach by clinicians to collect a complete family history of all cancers--particularly among first degree relatives--in order to assess patient risk for developing cancer," she said. "Families with clustering of different tumors may be particularly important to study in order to discover new genetic mutations to explain this clustering."
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2015-03-08
San Diego, CA--In patients with advanced thyroid cancer, sunitinib, a drug approved for treatment of several other cancers, showed significant cancer-fighting activity t, a new phase 2 clinical trial has found. Results of the single-center study will be presented Sunday at the Endocrine Society's 97th annual meeting in San Diego.
"Sunitinib can potentially be used as an effective adjunctive treatment in patients with advanced differentiated thyroid cancer," said Principal Investigator Kenneth Burman, MD, Chief of Endocrine at MedStar Washington Hospital Center, Washington, ...
2015-03-07
San Diego, CA-- A new testosterone nasal gel raises men's low testosterone levels to normal, with few side effects, according to the results of a phase 3 clinical trial to be presented Saturday at the Endocrine Society's 97th annual meeting in San Diego.
Last May, the U.S. Food and Drug Administration approved the medication, now called Natesto, making it the only FDA-approved nasal testosterone replacement therapy, according to the manufacturer, Trimel Pharmaceuticals.
"The unique delivery system makes this a convenient and easy-to-use, self-administered form of testosterone ...
2015-03-07
San Diego, CA-- Obstructive sleep apnea (OSA) is prevalent in obese, pregnant Asian women with gestational diabetes, even when their diabetes is controlled by diet, a new study from Thailand finds. Study results, which also connect the severity of sleep disordered breathing with higher blood glucose (sugar) levels and greater daytime sleepiness, will be presented on Saturday at the Endocrine Society's 97th annual meeting in San Diego.
In 25 women with diet-controlled gestational (pregnancy) diabetes, the researchers found a 56 percent prevalence of OSA, a sleep disorder ...
2015-03-07
San Diego, CA-- Obesity guidelines recommend an initial weight loss goal of 5 to 10% of start weight to improve health. A recent study found that patients who received liraglutide 3.0 mg, combined with fewer calories and more physical activity, were more than twice as likely to achieve at least that level of weight loss, compared to patients on placebo who made similar lifestyle changes. Patients who achieved that weight loss showed improvements on a number of health markers, compared to those who lost less, and the patients on liraglutide showed greater improvement on ...
2015-03-07
San Diego, CA-- A new study has confirmed that transgender youth often have mental health problems and that their depression and anxiety improve greatly with recognition and treatment of gender dysphoria. The results will be presented Saturday at The Endocrine Society's 97th annual meeting in San Diego.
"Youth with gender incongruence or dysphoria need a comprehensive, multidisciplinary approach to care," said principal investigator Maja Marinkovic, MD, a pediatric endocrinologist and Medical Director of the Gender Management Clinic at Rady Children's Hospital-San Diego, ...
2015-03-07
San Diego, CA-- A fetus exposed to tobacco smoke may be at increased risk for diabetes in adulthood, a new study of adult daughters finds. The results will be presented in a poster Saturday, March 7, at ENDO 2015, the annual meeting of the Endocrine Society in San Diego.
Women whose parents smoked during pregnancy had increased risk of diabetes mellitus independent of known risk factors, adding to the evidence that prenatal environmental chemical exposures can contribute to adult diabetes mellitus.
"From a public health perspective, reduced fetal environmental tobacco ...
2015-03-07
San Diego, CA--In older men, decreased sexual activity and desire, not erectile dysfunction, may cause serum testosterone to decline, a new study from Australia finds. The results will be presented Saturday March 7, at ENDO 2015, the annual meeting of the Endocrine Society, in San Diego.
"We found that over two years, men with declining serum concentrations of testosterone were more likely to develop a significant decrease in their sexual activity and sexual desire. In older men, decreased sexual activity and desire may be a cause - not an effect - of low circulating ...
2015-03-07
San Diego, CA--Why men have more heart disease than premenopausal women has been unclear, but a new study shows that the sex hormones testosterone and estrogen alter cardiovascular risk factors in a way that raises a man's risk of heart disease. Results of the study will be presented Saturday at the Endocrine Society's 97th annual meeting in San Diego.
Men have higher testosterone and lower estrogen levels than premenopausal women. Therefore, doctors have suspected that testosterone may promote cardiovascular disease or that estrogen may protect against it, or both, according ...
2015-03-07
San Diego, CA-- Breast cancer survivors are at increased risk of developing thyroid cancer, especially within five years of their breast cancer diagnosis, according to a new analysis of a large national database. The study results will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego.
"Recognition of this association between breast and thyroid cancer should prompt vigilant screening for thyroid cancer among breast cancer survivors," said lead investigator Jennifer Hong Kuo, MD, assistant professor of surgery at Columbia University, New ...
2015-03-07
San Diego, CA-- An experimental drug causes loss of weight and fat in mice, a new study has found. The study results will be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
Known as GC-1, the drug reportedly speeds up metabolism, or burning off, of fat cells.
"GC-1 dramatically increases the metabolic rate, essentially converting white fat, which stores excess calories and is associated with obesity and metabolic disease, into a fat like calorie-burning brown fat," said study author Kevin Phillips, PhD, a researcher at Houston Methodist ...
LAST 30 PRESS RELEASES:
[Press-News.org] Breast cancer risk may be increased in women who have first-degree relatives with a history of prostate cancer
